Nos publications
Mise à jour novembre 2023
Pagination
- Page précédente
- Page 4
- Page suivante
Title | Authors | Year Trier par ordre décroissant | Journal | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
Solving the dilemma of prevention of red cell alloimmunization | Branch DR | 2012 | Immunotherapy | View Solving the dilemma of prevention of red cell alloimmunization | Researchers | Other |
Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials | Lalu MM, McIntyre L, Pugliese C, Fergusson D, Winston BW, Marshall JC, Granton J, Stewart DJ, Canadian Critical Care Trials Group | 2012 | PLoS One | View Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials | Researchers | Clinical research |
The cell motility modulator Slit2 is a potent inhibitor of platelet function | Patel S, Huang YW, Reheman A, Pluthero FG, Chaturvedi S, Mukovozov IM, Tole S, Liu GY, Li L, Durocher Y, Ni H, Kahr WH, Robinson LA | 2012 | Circulation | View The cell motility modulator Slit2 is a potent inhibitor of platelet function | Researchers | Basic research |
Vascular endothelial dysfunction in beta-thalassemia occurs despite increased eNOS expression and preserved vascular smooth muscle cell reactivity to NO | Stoyanova E, Trudel M, Felfly H, Lemsaddek W, Garcia D, Cloutier G | 2012 | PLoS One | View Vascular endothelial dysfunction in beta-thalassemia occurs despite increased eNOS expression and preserved vascular smooth muscle cell reactivity to NO | Researchers | Basic research |
Encapsulation of factor IX-engineered mesenchymal stem cells in fibrinogen-alginate microcapsules enhances their viability and transgene secretion | Sayyar B, Dodd M, Wen J, Ma S, Marquez-Curtis L, Janowska-Wieczorek A, Hortelano G | 2012 | J Tissue Eng | View Encapsulation of factor IX-engineered mesenchymal stem cells in fibrinogen-alginate microcapsules enhances their viability and transgene secretion | Researchers | Basic research |
Evidence for a novel mechanism independent of myocardial iron in beta-thalassemia cardiac pathogenesis | Stoyanova E, Cloutier G, Felfly H, Lemsaddek W, Ah-Son N, Trudel M | 2012 | PLoS One | View Evidence for a novel mechanism independent of myocardial iron in beta-thalassemia cardiac pathogenesis | Researchers | Basic research |
Leaving nothing to chance: how to randomize a clinical trial | Toltl LJ, Arnold DM | 2012 | Transfusion | View Leaving nothing to chance: how to randomize a clinical trial | Researchers | Other |
Membrane Type-1 Matrix Metalloproteinase Expression in Acute Myeloid Leukemia and Its Upregulation by Tumor Necrosis Factor-? | Marquez-Curtis LA, Shirvaikar N, Turner AR, Mirza I, Surmawala A, Larratt LM, Janowska-Wieczorek A | 2012 | Cancers | View Membrane Type-1 Matrix Metalloproteinase Expression in Acute Myeloid Leukemia and Its Upregulation by Tumor Necrosis Factor-? | Researchers | Basic research |
Strict anaerobic Staphylococcus saccharolyticus isolates recovered from contaminated platelet concentrates fail to multiply during platelet storage | Ali H, Rood IG, de Korte D, Ramirez-Arcos S | 2012 | Transfusion | View Strict anaerobic Staphylococcus saccharolyticus isolates recovered from contaminated platelet concentrates fail to multiply during platelet storage | Researchers | Basic research |
Verotoxin A subunit protects lymphocytes and T cell lines against X4 HIV infection in vitro | Shi PL, Binnington B, Sakac D, Katsman Y, Ramkumar S, Gariepy J, Kim M, Branch DR, Lingwood C | 2012 | Toxins (Basel) | View Verotoxin A subunit protects lymphocytes and T cell lines against X4 HIV infection in vitro | Researchers | Basic research |
A systematic evaluation of laboratory testing for drug-induced immune thrombocytopenia | Arnold DM, Kukaswadia S, Nazi I, Esmail A, Dewar L, Smith JW, Warkentin TE, Kelton JG | 2013 | J Thromb Haemost | View A systematic evaluation of laboratory testing for drug-induced immune thrombocytopenia | Health care providers | Clinical research |
Bacterial growth in red blood cell units exposed to uncontrolled temperatures: challenging the 30-minute rule | Ramirez-Arcos S, Perkins H, Kou Y, Mastronardi C, Kumaran D, Taha M, Yi QL, McLaughlin N, Kahwash E, Lin Y, Acker J | 2013 | Vox Sang | View Bacterial growth in red blood cell units exposed to uncontrolled temperatures: challenging the 30-minute rule | Regulators | New or improved product or process |
Evaluating the 4-hour and 30-minute rules: effects of room temperature exposure on red blood cell quality and bacterial growth | Ramirez-Arcos S, Mastronardi C, Perkins H, Kou Y, Turner T, Mastronardi E, Hansen A, Yi QL, McLaughlin N, Kahwash E, Lin Y, Acker J | 2013 | Transfusion | View Evaluating the 4-hour and 30-minute rules: effects of room temperature exposure on red blood cell quality and bacterial growth | Regulators | New or improved product or process |
FcgRIIa proteolysis as a diagnostic biomarker for heparin-induced thrombocytopenia | Nazi I, Arnold DM, Smith JW, Horsewood P, Moore JC, Warkentin TE, Crowther MA, Kelton JG | 2013 | J Thromb Haemost | View FcgRIIa proteolysis as a diagnostic biomarker for heparin-induced thrombocytopenia | Researchers | Basic research |
Co-stimulation with LPS or Poly I:C markedly enhances the anti-platelet immune response and severity of fetal and neonatal alloimmune thrombocytopenia | Li C, Chen P, Vadasz B, Ma L, Zhou H, Lang S, Freedman J, Ni H | 2013 | Thromb Haemost | View Co-stimulation with LPS or Poly I:C markedly enhances the anti-platelet immune response and severity of fetal and neonatal alloimmune thrombocytopenia | Researchers | Basic research |
Quality of red blood cells washed using the ACP 215 cell processor: assessment of optimal pre- and postwash storage times and conditions | Hansen A, Yi QL, Acker JP | 2013 | Transfusion | View Quality of red blood cells washed using the ACP 215 cell processor: assessment of optimal pre- and postwash storage times and conditions | Researchers | New or improved product or process |
Adjudication of bleeding outcomes in an international thromboprophylaxis trial in critical illness | Arnold DM, Lauzier F, Rabbat C, Zytaruk N, Barlow Cash B, Clarke F, Heels-Ansdell D, Guyatt G, Walter SD, Davies A, Cook DJ, PROTECT Investigators on behalf of the Canadian Critical Care Trials Group and the Australian and New Zealand Intensive Care Clinical Trials Group | 2013 | Thromb Res | View Adjudication of bleeding outcomes in an international thromboprophylaxis trial in critical illness | Researchers | Clinical research |
Challenges in the management of the blood supply | Williamson LM, Devine DV | 2013 | Lancet | View Challenges in the management of the blood supply | Blood operators | Other |
Fusion of the C-terminal triskaidecapeptide of hirudin variant 3 to alpha1-proteinase inhibitor M358R increases the serpin-mediated rate of thrombin inhibition | Roddick LA, Bhakta V, Sheffield W | 2013 | BMC Biochem | View Fusion of the C-terminal triskaidecapeptide of hirudin variant 3 to alpha1-proteinase inhibitor M358R increases the serpin-mediated rate of thrombin inhibition | Researchers | Basic research |
Legal Aspects of the Blood System in Canada | Reis NM | 2013 | Public Health Law and Policy in Canada | View Legal Aspects of the Blood System in Canada | Other | Other |
A case of vertical transmission of Chagas Disease contracted via blood transfusion in Canada | Fearon MA, Scalia V, Huang M, Dines I, Ndao M | 2013 | Can J Infect Dis Med Microbiol | View A case of vertical transmission of Chagas Disease contracted via blood transfusion in Canada | Health care providers | Clinical research |
Positioning new treatments in the management of immune thrombocytopenia | Arnold DM | 2013 | Pediatr Blood Cancer | View Positioning new treatments in the management of immune thrombocytopenia | Researchers | Clinical research |
Amelioration of Murine Passive Immune Thrombocytopenia by IVIg and a Therapeutic Monoclonal CD44 Antibody Does Not Require the Myd88 Signaling Pathway | Crow AR, Yu H, Han D, Lazarus AH | 2013 | PLoS One | View Amelioration of Murine Passive Immune Thrombocytopenia by IVIg and a Therapeutic Monoclonal CD44 Antibody Does Not Require the Myd88 Signaling Pathway | Researchers | Basic research |
Donor hemovigilance | Goldman M | 2013 | Blood Transfus | View Donor hemovigilance | Health care providers | Other |
Expert approaches to common bleeding and thrombotic problems, part II | Hayward CP, Webert KE | 2013 | Semin Thromb Hemost | View Expert approaches to common bleeding and thrombotic problems, part II | Health care providers | Other |
Research with Blood Donated to Blood Banking Organizations | Reis NM | 2013 | Health Law Review | View Research with Blood Donated to Blood Banking Organizations | Other | Other |
Utility of cross-matched platelet transfusions in patients with hypoproliferative thrombocytopenia: a systematic review | Vassallo RR, Fung M, Rebulla P, Duquesnoy R, Saw CL, Slichter SJ, Tanael S, Shehata N, International Collaboration for Guideline Development Implementation Evaluation for Transfusion Therapies Collaborators | 2013 | Transfusion | View Utility of cross-matched platelet transfusions in patients with hypoproliferative thrombocytopenia: a systematic review | Researchers | Clinical research |
A platelet cover-up | Arnold DM | 2013 | Blood | View A platelet cover-up | Researchers | Other |
Legal Foundations of Public Health Law | Reis NM | 2013 | Public Health Law and Policy in Canada | View Legal Foundations of Public Health Law | Other | Other |
Phospholipidomics reveals differences in glycerophosphoserine profiles of hypothermically stored red blood cells and microvesicles | Bicalho B, Holovati JL, Acker JP | 2013 | Biochim Biophys Acta | View Phospholipidomics reveals differences in glycerophosphoserine profiles of hypothermically stored red blood cells and microvesicles | Researchers | Basic research |
The complete N-terminal extension of heparin cofactor II is required for maximal effectiveness as a thrombin exosite 1 ligand | Boyle AJ, Roddick LA, Bhakta V, Lambourne MD, Junop MS, Liaw PC, Weitz JI, Sheffield WP | 2013 | BMC Biochem | View The complete N-terminal extension of heparin cofactor II is required for maximal effectiveness as a thrombin exosite 1 ligand | Researchers | Basic research |
Alloimmunization of patients by blood units harboring distinct DEL variants | St-Louis M, Lebrun A, Goldman M, Lavoie M | 2013 | Immunohematology | View Alloimmunization of patients by blood units harboring distinct DEL variants | Health care providers | Clinical research |
Fc-independent phagocytosis: Implications for IVIG and other therapies in immune-mediated thrombocytopenia | Li J, van der Wal DE, Zhu L, Vadasz B, Simpson EK, Li C, Webster ML, Zhu G, Lang S, Chen P, Zeng Q, Ni H | 2013 | Cardiovasc Hematol Disord Drug Targets | View Fc-independent phagocytosis: Implications for IVIG and other therapies in immune-mediated thrombocytopenia | Researchers | Other |
Identifying D-positive donors using a second automated testing platform | Goldman M, Resz I, Cote J, Ochoa G, Angus N | 2013 | Immunohematology | View Identifying D-positive donors using a second automated testing platform | Blood operators | New or improved product or process |
Riboflavin and ultraviolet light treatment of platelets triggers p38MAPK signaling: inhibition significantly improves in vitro platelet quality after pathogen reduction treatment | Schubert P, Coupland D, Culibrk B, Goodrich RP, Devine DV | 2013 | Transfusion | View Riboflavin and ultraviolet light treatment of platelets triggers p38MAPK signaling: inhibition significantly improves in vitro platelet quality after pathogen reduction treatment | Researchers | Basic research |
CD4+ T-cells are unable to express the HIV natural resistance factor globotriosylceramide | Kim M, Binnington B, Sakac D, Lingwood CA, Branch DR | 2013 | AIDS | View CD4+ T-cells are unable to express the HIV natural resistance factor globotriosylceramide | Researchers | Basic research |
Developing highly active small molecule ice recrystallization inhibitors based upon C-linked antifreeze glycoprotein analogues | Trant JF, Briggs RA, Capicciotti C, Ben RN | 2013 | RSC Adv | View Developing highly active small molecule ice recrystallization inhibitors based upon C-linked antifreeze glycoprotein analogues | Researchers | Basic research |
ResearchUnit: Should patients receive HLA-selected platelets? | Shehata N | 2013 | Blood.ca website | View ResearchUnit: Should patients receive HLA-selected platelets? | Other | Other |
Utilization of frozen plasma in Ontario: a province wide audit reveals a high rate of inappropriate transfusions | Tinmouth A, Thompson T, Arnold DM, Callum JL, Gagliardi K, Lauzon D, Owens W, Pinkerton P | 2013 | Transfusion | View Utilization of frozen plasma in Ontario: a province wide audit reveals a high rate of inappropriate transfusions | Health care providers | Benchmarking and standard setting |
Progressive development of polycystic kidney disease in the mouse model expressing Pkd1 extracellular domain | Kurbegovic A, Trudel M | 2013 | Hum Mol Genet | View Progressive development of polycystic kidney disease in the mouse model expressing Pkd1 extracellular domain | Researchers | Basic research |
ResearchUnit: Doubling the 30-minute rule without compromising Red Blood Cells quality and safety. | Ramirez-Arcos S | 2013 | Blood.ca website | View ResearchUnit: Doubling the 30-minute rule without compromising Red Blood Cells quality and safety. | Other | Other |
Thrombocytopenia in the critically ill | Shehata N, Fontes ML | 2013 | Can J Anaesth | View Thrombocytopenia in the critically ill | Researchers | Other |
Allowing blood donation from men who had sex with men more than 5Â years ago: a model to evaluate the impact on transfusion safety in Canada | Germain M, Robillard P, Delage G, Goldman M | 2013 | Vox Sang | View Allowing blood donation from men who had sex with men more than 5Â years ago: a model to evaluate the impact on transfusion safety in Canada | Blood operators | New or improved product or process |
Design of long circulating nontoxic dendritic polymers for the removal of iron in vivo | Imran ul-haq M, Hamilton JL, Lai BF, Shenoi RA, Horte S, Constantinescu I, Leitch HA, Kizhakkedathu JN | 2013 | ACS Nano | View Design of long circulating nontoxic dendritic polymers for the removal of iron in vivo | Researchers | Basic research |
Efficacy of HLA-matched platelet transfusions for patients with hypoproliferative thrombocytopenia: a systematic review | Pavenski K, Rebulla P, Duquesnoy R, Saw CL, Slichter SJ, Tanael S, Shehata N, International Collaboration for Guideline Development Implementation and Evaluation for Transfusion Therapies (ICTMG) Collaborators | 2013 | Transfusion | View Efficacy of HLA-matched platelet transfusions for patients with hypoproliferative thrombocytopenia: a systematic review | Researchers | Clinical research |
N-ethylmaleimide activates a Cl(-)-independent component of K(+) flux in mouse erythrocytes | Shmukler BE, Hsu A, Alves J, Trudel M, Rust MB, Hubner CA, Rivera A, Alper SL | 2013 | Blood Cells Mol Dis | View N-ethylmaleimide activates a Cl(-)-independent component of K(+) flux in mouse erythrocytes | Researchers | Basic research |
Posttransplant monitoring of de novo human leukocyte antigen donor-specific antibodies in kidney transplantation | Wiebe C, Nickerson P | 2013 | Curr Opin Organ Transplant | View Posttransplant monitoring of de novo human leukocyte antigen donor-specific antibodies in kidney transplantation | Health care providers | Clinical research |
Sustained remissions of immune thrombocytopenia associated with the use of thrombopoietin receptor agonists | Ghadaki B, Nazi I, Kelton JG, Arnold DM | 2013 | Transfusion | View Sustained remissions of immune thrombocytopenia associated with the use of thrombopoietin receptor agonists | Health care providers | Clinical research |
Unraveling the IVIG mystique | Branch DR | 2013 | Transfusion | View Unraveling the IVIG mystique | Researchers | Other |
What should men living with severe haemophilia need to know? The perspectives of Canadian haemophilia health care providers | Lane S, Arnold E, Webert KE, Chan A, Walker I, Heddle NM | 2013 | Haemophilia | View What should men living with severe haemophilia need to know? The perspectives of Canadian haemophilia health care providers | Health care providers | Other |